• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.

作者信息

van 't Veer L J, Beijersbergen R L, Bernards R

机构信息

Division of Molecular Genetics, Massachusetts General Hospital, Charlestown 02129.

出版信息

EMBO J. 1993 Jan;12(1):195-200. doi: 10.1002/j.1460-2075.1993.tb05645.x.

DOI:10.1002/j.1460-2075.1993.tb05645.x
PMID:8428579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC413191/
Abstract

In neuroblastoma, N-myc suppresses the expression of major histocompatibility complex (MHC) Class I antigens by reducing the binding of a nuclear factor to the enhancer-A element in the MHC Class I gene promoter. We show here that the p50 subunit of NF-kappa B is part of this complex and that expression of p50 mRNA is suppressed by N-myc. Transfection of a p50 expression vector in neuroblastoma cells that express N-myc at a high level leads to restoration of factor binding to the MHC Class I gene enhancer, restores enhancer activity and leads to re-expression of MHC Class I antigens at the cell surface. These data indicate that the p50 subunit of NF-kappa B is involved in the regulation of MHC Class I antigen expression and that N-myc down-regulates MHC Class I gene expression primarily through suppression of p50 expression.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/bb9f28928799/emboj00073-0206-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/573e77193626/emboj00073-0204-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/52a73799115e/emboj00073-0205-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/648eb490cb52/emboj00073-0205-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/a2c5b1eed971/emboj00073-0206-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/bb9f28928799/emboj00073-0206-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/573e77193626/emboj00073-0204-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/52a73799115e/emboj00073-0205-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/648eb490cb52/emboj00073-0205-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/a2c5b1eed971/emboj00073-0206-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7138/413191/bb9f28928799/emboj00073-0206-b.jpg

相似文献

1
N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.
EMBO J. 1993 Jan;12(1):195-200. doi: 10.1002/j.1460-2075.1993.tb05645.x.
2
Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-kappa B.
J Biol Chem. 1995 May 12;270(19):11453-62. doi: 10.1074/jbc.270.19.11453.
3
Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B.碘化物对甲状腺细胞中主要组织相容性复合体I类基因表达的抑制作用涉及增强子A和转录因子核因子κB。
Mol Endocrinol. 1998 Jan;12(1):19-33. doi: 10.1210/mend.12.1.0052.
4
Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.在缺乏I类抗原表达的人肿瘤细胞系中,调节因子与HLA I类增强子序列的结合发生改变。
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3488-92. doi: 10.1073/pnas.89.8.3488.
5
Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A.由于腺病毒12 E1A干扰p105-NFκB1加工导致MHC I类分子表达下调。
EMBO J. 1995 Apr 3;14(7):1498-507. doi: 10.1002/j.1460-2075.1995.tb07136.x.
6
NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells.NF-κB 而非 MYCN 调控人类神经母细胞瘤细胞中的 MHC Ⅰ类分子和内质网氨基肽酶。
Cancer Res. 2010 Feb 1;70(3):916-24. doi: 10.1158/0008-5472.CAN-09-2582. Epub 2010 Jan 26.
7
I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.IκB/MAD-3掩盖了NF-κB p65的核定位信号,并且需要反式激活结构域来抑制NF-κB p65与DNA的结合。
Mol Biol Cell. 1992 Dec;3(12):1339-52. doi: 10.1091/mbc.3.12.1339.
8
Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif.通过核因子κB增强子基序对VCAM-1启动子进行细胞类型特异性反式激活。
J Biol Chem. 1995 Apr 14;270(15):8976-83. doi: 10.1074/jbc.270.15.8976.
9
Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B.人类1型T细胞白血病病毒的tax蛋白对c-myc启动子的反式激活作用是由核因子κB介导的。
J Biol Chem. 1992 Aug 15;267(23):16288-91.
10
NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.免疫球蛋白重链增强子对c-myc表达的失调需要NF-κB活性。
J Biol Chem. 2000 Oct 13;275(41):32338-46. doi: 10.1074/jbc.M004148200.

引用本文的文献

1
Challenges and solutions for therapeutic TCR-based agents.治疗性 TCR 为基础的药物的挑战和解决方案。
Immunol Rev. 2023 Nov;320(1):58-82. doi: 10.1111/imr.13233. Epub 2023 Jul 16.
2
Impaired Antitumor Immune Response in -amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment.CCL2 分泌缺失和树突状细胞募集不良导致扩增神经母细胞瘤抗肿瘤免疫应答受损。
Cancer Res Commun. 2022 Jul 5;2(7):577-589. doi: 10.1158/2767-9764.CRC-21-0134. eCollection 2022 Jul.
3
Igniting Hope for Tumor Immunotherapy: Promoting the "Hot and Cold" Tumor Transition.

本文引用的文献

1
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.大肠杆菌lacZ基因融合体在哺乳动物细胞中的表达与调控
J Mol Appl Genet. 1983;2(1):101-9.
2
A new technique for the assay of infectivity of human adenovirus 5 DNA.一种检测人腺病毒5型DNA感染性的新技术。
Virology. 1973 Apr;52(2):456-67. doi: 10.1016/0042-6822(73)90341-3.
3
Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene.一种核因子与小鼠H-2Kb I类主要组织相容性基因启动子中的调控序列的结合。
点燃肿瘤免疫治疗的希望:促进“冷”“热”肿瘤转变
Clin Med Insights Oncol. 2022 Sep 15;16:11795549221120708. doi: 10.1177/11795549221120708. eCollection 2022.
4
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.通过 MHC I 类抗原呈递丧失实现癌症免疫逃逸。
Front Immunol. 2021 Mar 9;12:636568. doi: 10.3389/fimmu.2021.636568. eCollection 2021.
5
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.癌症中MHC I类分子下调:潜在机制及癌症免疫治疗的潜在靶点
Cancers (Basel). 2020 Jul 2;12(7):1760. doi: 10.3390/cancers12071760.
6
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.多梳抑制复合物的一个进化保守功能是沉默 MHC I 抗原呈递途径,并使癌症能够免疫逃逸。
Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26.
7
The MYC oncogene is a global regulator of the immune response.MYC 癌基因是免疫反应的全局调节剂。
Blood. 2018 May 3;131(18):2007-2015. doi: 10.1182/blood-2017-11-742577. Epub 2018 Mar 7.
8
Cancer Immunotherapy: Whence and Whither.癌症免疫疗法:起源与发展方向
Mol Cancer Res. 2017 Jun;15(6):635-650. doi: 10.1158/1541-7786.MCR-16-0427. Epub 2017 Mar 29.
9
Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-α.脯氨酰-4-羟化酶2通过调节缺氧诱导因子-α的基因表达增强缺氧诱导的胶质母细胞瘤细胞死亡。
Cell Death Dis. 2014 Jul 10;5(7):e1322. doi: 10.1038/cddis.2014.295.
10
Identifying regulatory mechanisms underlying tumorigenesis using locus expression signature analysis.利用基因座表达特征分析鉴定肿瘤发生的调控机制。
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5747-52. doi: 10.1073/pnas.1309293111. Epub 2014 Apr 2.
Mol Cell Biol. 1987 Jan;7(1):305-13. doi: 10.1128/mcb.7.1.305-313.1987.
4
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes.一种常见的正向反式作用因子与小鼠H-2和β2-微球蛋白基因启动子中的增强子序列结合。
Proc Natl Acad Sci U S A. 1987 May;84(9):2653-7. doi: 10.1073/pnas.84.9.2653.
5
Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.两种转录因子,核因子κB(NF-κB)和H2TF1,与I类主要组织相容性复合体启动子中的单一调控序列相互作用。
Proc Natl Acad Sci U S A. 1988 Feb;85(3):723-7. doi: 10.1073/pnas.85.3.723.
6
A simple phase-extraction assay for chloramphenicol acyltransferase activity.一种用于氯霉素酰基转移酶活性的简单相萃取测定法。
Gene. 1988 Jul 30;67(2):271-7. doi: 10.1016/0378-1119(88)90403-9.
7
Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.与核因子NF-κB结合的寡核苷酸充当淋巴细胞特异性且可诱导的增强子元件。
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1482-6. doi: 10.1073/pnas.85.5.1482.
8
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.κ免疫球蛋白增强子结合蛋白Nf-κB通过翻译后机制的可诱导性。
Cell. 1986 Dec 26;47(6):921-8. doi: 10.1016/0092-8674(86)90807-x.
9
N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma.N-myc基因扩增导致神经母细胞瘤中MHC I类抗原表达下调。
Cell. 1986 Dec 5;47(5):667-74. doi: 10.1016/0092-8674(86)90509-x.
10
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.核因子κB:诱导性和组织特异性基因调控的多效性介质
Cell. 1989 Jul 28;58(2):227-9. doi: 10.1016/0092-8674(89)90833-7.